12.17.00: Dain Rauscher Wessels Healthcare & Life Sciences 2000 Conference
Four leading analysts and top management from twenty sector firms examine the Healthcare Industry in this special 95-page Dain Rauscher Wessels Healthcare & Life Sciences 2000 Conference issue from The Wall Street Transcript.

    Online subscribers to the healthcare sector also get
    Biotechnology Industry Issue & Medical Technology & Devices Issue

  1. Medical Technology - In an in-depth (8,100 words) Analyst Interview, Sanjiv Arora, Managing Director at Dain Rauscher Wessels, examines the outlook for the sector, including an overview of the medical technology group, and shares specific stock recommendations.
  2. Healthcare Information Technology & Services - In an in-depth (3,600 words) Analyst Interview, Jeffrey Peters, Vice President at Dain Rauscher Wessels, examines the outlook for the sector, and shares specific stock recommendations.
  3. Ophthalmology & Vision Care - In an in-depth (4,900 words) Analyst Interview, David Therkelsen, Vice President at Dain Rauscher Wessels, examines the outlook for the sector, including an overview of the ophthalmology and vision care space, impact of mergers and acquisitions, and shares specific stock recommendations.
  4. Biopharmaceuticals - In an in-depth (6,500 words) Analyst Interview, Andrew Milne, Vice President at Dain Rauscher Wessels, examines the outlook for the sector, including key trends and issues that will impact biopharmaceutical companies over the next 12 months, and shares specific stock recommendations.
  5. CEO interviews (average 2,500 words). Top management of twenty sector firms examine the outlook for their firm and the sector. Firms include:
    Allscripts, AVANT Immunotherapeutics, Biomet, Cerner, Cerus, Curis, eBenX, INNERCOOL Therapies, INTRACEL, IRIDEX, LCA-Vision, Medarex, MedSource Technologies, Novoste, Oculex Pharmaceuticals, Refractec, Ribozyme Pharmaceuticals, Spinal Concepts, TERAMED, V.I. Technologies.
    6. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE